@...@ The company*s shares fell as much as 28 percent© to a 13~month low of $7//27 in afternoon trade before halving the losses//
Onivyde, in combination with chemotherapy treatments 5~fluorouracil and leucovorin, aims to treat metastatic pancreatic cancer in patients, who ©have failed to respond to chemotherapy drug gemcitabine//
@...@ But the drug, Merrimack*s first to win regulatory clearance, ©carries a black box warning, FDA*s most severe and restrictive warning on a product//
The warning flags severe risks of diarrhea and low white blood cell count//
Pancreatic cancer, known as the **deadliest** kind of cancer, is seldom detected in its early stages and is responsible for 7 percent of cancer deaths in the© United States, according to the American Cancer Society//
There will be 48,960 new cases of pancreatic cancer diagnosed in the United States this year, the National Cancer Institute estimates//